410 related articles for article (PubMed ID: 26410133)
1. Diagnostic Criteria for Acute Kidney Injury: Present and Future.
Kellum JA
Crit Care Clin; 2015 Oct; 31(4):621-32. PubMed ID: 26410133
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of renal function, which and when?
Wasung ME; Chawla LS; Madero M
Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers in Acute Kidney Injury.
Chen LX; Koyner JL
Crit Care Clin; 2015 Oct; 31(4):633-48. PubMed ID: 26410134
[TBL] [Abstract][Full Text] [Related]
4. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.
Vijayan A; Faubel S; Askenazi DJ; Cerda J; Fissell WH; Heung M; Humphreys BD; Koyner JL; Liu KD; Mour G; Nolin TD; Bihorac A;
Am J Kidney Dis; 2016 Jul; 68(1):19-28. PubMed ID: 26948834
[TBL] [Abstract][Full Text] [Related]
5. Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers.
Dusse F; Edayadiyil-Dudásova M; Thielmann M; Wendt D; Kahlert P; Demircioglu E; Jakob H; Schaefer ST; Pilarczyk K
BMC Anesthesiol; 2016 Sep; 16():76. PubMed ID: 27609347
[TBL] [Abstract][Full Text] [Related]
6. Use of Cell Cycle Arrest Biomarkers in Conjunction With Classical Markers of Acute Kidney Injury.
Joannidis M; Forni LG; Haase M; Koyner J; Shi J; Kashani K; Chawla LS; Kellum JA;
Crit Care Med; 2019 Oct; 47(10):e820-e826. PubMed ID: 31343478
[TBL] [Abstract][Full Text] [Related]
7. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial.
Meersch M; Schmidt C; Hoffmeier A; Van Aken H; Wempe C; Gerss J; Zarbock A
Intensive Care Med; 2017 Nov; 43(11):1551-1561. PubMed ID: 28110412
[TBL] [Abstract][Full Text] [Related]
8. Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients.
Daubin D; Cristol JP; Dupuy AM; Kuster N; Besnard N; Platon L; Buzançais A; Brunot V; Garnier F; Jonquet O; Klouche K
PLoS One; 2017; 12(1):e0169674. PubMed ID: 28085896
[TBL] [Abstract][Full Text] [Related]
9. Biomarker-guided Intervention to Prevent Acute Kidney Injury After Major Surgery: The Prospective Randomized BigpAK Study.
Göcze I; Jauch D; Götz M; Kennedy P; Jung B; Zeman F; Gnewuch C; Graf BM; Gnann W; Banas B; Bein T; Schlitt HJ; Bergler T
Ann Surg; 2018 Jun; 267(6):1013-1020. PubMed ID: 28857811
[TBL] [Abstract][Full Text] [Related]
10. Biomarker-Guided Risk Assessment for Acute Kidney Injury: Time for Clinical Implementation?
Albert C; Haase M; Albert A; Zapf A; Braun-Dullaeus RC; Haase-Fielitz A
Ann Lab Med; 2021 Jan; 41(1):1-15. PubMed ID: 32829575
[TBL] [Abstract][Full Text] [Related]
11. Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury.
Westhoff JH; Tönshoff B; Waldherr S; Pöschl J; Teufel U; Westhoff TH; Fichtner A
PLoS One; 2015; 10(11):e0143628. PubMed ID: 26606754
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
[TBL] [Abstract][Full Text] [Related]
13. [Acute kidney injury].
Bienholz A; Feldkamp T; Kribben A;
Dtsch Med Wochenschr; 2013 Jun; 138(23):1229-32. PubMed ID: 23720177
[No Abstract] [Full Text] [Related]
14. Classifying AKI by Urine Output versus Serum Creatinine Level.
Kellum JA; Sileanu FE; Murugan R; Lucko N; Shaw AD; Clermont G
J Am Soc Nephrol; 2015 Sep; 26(9):2231-8. PubMed ID: 25568178
[TBL] [Abstract][Full Text] [Related]
15. Risk prediction of acute kidney injury by [TIMP-2]•[IGFBP7].
Kimmel M; Schanz M; Alscher MD
Drugs Today (Barc); 2017 Jun; 53(6):349-356. PubMed ID: 28799580
[TBL] [Abstract][Full Text] [Related]
16. Urinary [TIMP-2]·[IGFBP7]-guided randomized controlled intervention trial to prevent acute kidney injury in the emergency department.
Schanz M; Wasser C; Allgaeuer S; Schricker S; Dippon J; Alscher MD; Kimmel M
Nephrol Dial Transplant; 2019 Nov; 34(11):1902-1909. PubMed ID: 29961888
[TBL] [Abstract][Full Text] [Related]
17. Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Risk Stratification of Acute Kidney Injury in Patients With Sepsis.
Honore PM; Nguyen HB; Gong M; Chawla LS; Bagshaw SM; Artigas A; Shi J; Joannes-Boyau O; Vincent JL; Kellum JA;
Crit Care Med; 2016 Oct; 44(10):1851-60. PubMed ID: 27355527
[TBL] [Abstract][Full Text] [Related]
18. Urine cell cycle arrest biomarkers distinguish poorly between transient and persistent AKI in early septic shock: a prospective, multicenter study.
Titeca-Beauport D; Daubin D; Van Vong L; Belliard G; Bruel C; Alaya S; Chaoui K; Andrieu M; Rouquette-Vincenti I; Godde F; Pascal M; Diouf M; Vinsonneau C; Klouche K; Maizel J
Crit Care; 2020 Jun; 24(1):280. PubMed ID: 32487237
[TBL] [Abstract][Full Text] [Related]
19. NephroCheck data compared to serum creatinine in various clinical settings.
Pajenda S; Ilhan-Mutlu A; Preusser M; Roka S; Druml W; Wagner L
BMC Nephrol; 2015 Dec; 16():206. PubMed ID: 26651477
[TBL] [Abstract][Full Text] [Related]
20. Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice.
Fan W; Ankawi G; Zhang J; Digvijay K; Giavarina D; Yin Y; Ronco C
Clin Chem Lab Med; 2019 Apr; 57(5):567-576. PubMed ID: 30179848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
